Clinical Trial Detail

NCT ID NCT02567396
Title Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

Therapies

Talazoparib

Age Groups: adult

No variant requirements are available.